Search research articles
Contact Us
Filters
Showing results (351-360 of 958) with videos related to
Page
of 96
Sort By:
European Respiratory Review : an Official Journal of the European Respiratory Society
|
September 17, 2025
SOX17 in pulmonary arterial hypertension: from development to clinical phenotype
Thomas Lacoste-Palasset, Benoit Aguado, Julien Grynblat, et al.
Pediatric Research
|
April 17, 2008
Safety experience with bosentan in 146 children 2-11 years old with pulmonary arterial hypertension: results from the European Postmarketing Surveillance program
Maurice Beghetti, Marius M Hoeper, David G Kiely, et al.
Circulation
|
March 26, 2014
Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay
Alice Huertas, Frédéric Perros, Ly Tu, et al.
Chest
|
March 19, 2013
Does omalizumab make a difference to the real-life treatment of asthma exacerbations?: Results from a large cohort of patients with severe uncontrolled asthma
Lamiae Grimaldi-Bensouda, Mahmoud Zureik, Michel Aubier, et al.
Thrombosis and Haemostasis
|
September 8, 2012
Development of prognostic tools in pulmonary arterial hypertension: lessons from modern day registries
Raymond L Benza, Mardi Gomberg-Maitland, Adaani E Frost, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
December 6, 2011
Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: an observational study
Kristina Kemp, Laurent Savale, Dermot S O'Callaghan, et al.
Respiratory Medicine
|
April 27, 2010
Evidence for the use of combination targeted therapeutic approaches for the management of pulmonary arterial hypertension
Dermot S O'Callaghan, Laurent Savale, Xavier Jaïs, et al.
Arthritis and Rheumatism
|
February 2, 2008
Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases
Xavier Jais, David Launay, Azzedine Yaici, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
October 19, 2019
Efficacy of Intravenous Reslizumab in Oral Corticosteroid-Dependent Asthma
Parameswaran Nair, Philip Bardin, Marc Humbert, et al.
Respiratory Medicine
|
December 24, 2014
Perceived 10-year change in respiratory health: reliability and predictive ability
Margaux Sanchez, Raphaëlle Varraso, Jean Bousquet, et al.
Page
of 96
Search research articles
Search
Showing results (351-360 of 958) with videos related to
Sort By:
Page
of 96
European Respiratory Review : an Official Journal of the European Respiratory Society
|
September 17, 2025
SOX17 in pulmonary arterial hypertension: from development to clinical phenotype
Thomas Lacoste-Palasset, Benoit Aguado, Julien Grynblat, et al.
Pediatric Research
|
April 17, 2008
Safety experience with bosentan in 146 children 2-11 years old with pulmonary arterial hypertension: results from the European Postmarketing Surveillance program
Maurice Beghetti, Marius M Hoeper, David G Kiely, et al.
Circulation
|
March 26, 2014
Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay
Alice Huertas, Frédéric Perros, Ly Tu, et al.
Chest
|
March 19, 2013
Does omalizumab make a difference to the real-life treatment of asthma exacerbations?: Results from a large cohort of patients with severe uncontrolled asthma
Lamiae Grimaldi-Bensouda, Mahmoud Zureik, Michel Aubier, et al.
Thrombosis and Haemostasis
|
September 8, 2012
Development of prognostic tools in pulmonary arterial hypertension: lessons from modern day registries
Raymond L Benza, Mardi Gomberg-Maitland, Adaani E Frost, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
December 6, 2011
Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: an observational study
Kristina Kemp, Laurent Savale, Dermot S O'Callaghan, et al.
Respiratory Medicine
|
April 27, 2010
Evidence for the use of combination targeted therapeutic approaches for the management of pulmonary arterial hypertension
Dermot S O'Callaghan, Laurent Savale, Xavier Jaïs, et al.
Arthritis and Rheumatism
|
February 2, 2008
Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases
Xavier Jais, David Launay, Azzedine Yaici, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
October 19, 2019
Efficacy of Intravenous Reslizumab in Oral Corticosteroid-Dependent Asthma
Parameswaran Nair, Philip Bardin, Marc Humbert, et al.
Respiratory Medicine
|
December 24, 2014
Perceived 10-year change in respiratory health: reliability and predictive ability
Margaux Sanchez, Raphaëlle Varraso, Jean Bousquet, et al.
Page
of 96